May. 21 at 9:23 PM
Which stocks are better buys at current levels?
$NVDA at
$221
$OSCR at
$22
$HIMS at
$24
$PLTR at
$137
$NOW at
$99
Great watchlist! This perfectly captures the clash between "Big Tech AI" and "High-Growth Digital Health."
At current levels, we are seeing a clear split:
Tech Alliance:
$NVDA (
$221) remains the AI king, backed by
$PLTR (
$137)'s software momentum and
$NOW (
$99)'s enterprise moat.
Health Contenders:
$HIMS (
$24) and
$OSCR (
$22) offer massive growth elasticity at highly tempting entry points.
Would you play it safe with the heavy-hitting tech giants, or chase the risk-reward alpha in digital health?
Which one is your absolute "Best Buy" right now? Drop your ticker and reasons below!